Sign inGet started

Brusegard David

Insider CIK 1516920 · GNBT Chief Operating Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise deriv2016-02-162016-02-161,667,671— $00SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise2016-02-162016-02-161,667,671— $05,615,070SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise deriv2016-02-092016-02-12546,448— $00SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise deriv2016-02-092016-02-121,928,925— $00SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise deriv2016-02-092016-02-12595,239— $00SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise deriv2016-02-092016-02-12845,492— $00SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise deriv2016-02-092016-02-121,667,671— $01,667,671SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP M Exercise2016-02-092016-02-125,583,775— $03,916,104SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP A Award deriv2013-10-312013-11-01845,492— $0845,492SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP A Award deriv2013-06-062013-06-10595,239— $0595,239SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP A Award deriv2013-04-012013-04-011,928,925— $01,928,925SEC↗
GNBT GENEREX BIOTECHNOLOGY CORP A Award deriv2012-06-202012-06-21546,448— $0546,448SEC↗